Corona Virus Disease 2019
Conditions
Interventions
Experimental group:Conventional medication + Infusion of mesenchymal stem cells
Sponsors
Huangshi Hospital of Traditional Chinese Medicine (Municipal Infectious Disease Hospital)
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: (1) Aged 18 to 90 years old, male or female; (2) Patients with a definite diagnosis of new type of coronavirus pneumonia; (3) Expected survival time > 10 days; (4) Serology: HIV antibody negative; hepatitis B surface antigen, e antigen negative; hepatitis C antibody negative; female patients with negative pregnancy test; ALT, AST <=2.5 ULN; for patients with liver metastases, ALT, AST <=5 ULN; ALP <=2.5 ULN; serum urea nitrogen and creatinine <=1.5 ULN; serum total bilirubin <1.5 times the upper limit of normal; (6) Patients or their legal representatives can understand and voluntarily sign informed consent.
Exclusion criteria
Exclusion criteria: 1. With any autoimmune disease; 2. with malignant tumors; 3. Participated in other clinical studies within three months before entering the group; 4. Severe allergic history, allergic to T cell therapy products or other biological agents; 5. Pregnant, planning to become pregnant or lactating women; 6. Patients with severe systemic diseases who are not suitable for entering the study, including but not limited to severe liver dysfunction, severe coagulation disorders, severe mental diseases, etc.; 7. Previously received other stem cell therapy, had received CIK cell therapy within two months; 8. Researchers believe that other conditions should not be included in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chest Imaging;lung function;ADL; | — |
Countries
China
Contacts
Public ContactFeng Ganzhu
Huangshi Hospital of Traditional Chinese Medicine
Outcome results
None listed